Table 3.
Characteristic | Quartile 1 (95.8 to 130.1) (n = 63) | Quartile 2 (130.2 to 143.7) (n = 63) | Quartile 3 (143.8 to 156.5) (n = 63) | Quartile 4 (156.5 to 201.0) (n = 63) | Odds Ratio | 95% Confidence Interval | P |
---|---|---|---|---|---|---|---|
Age (median, range, years) | 62 (32 to 83) | 62 (20 to 84) | 59 (28 to 84) | 61 (38 to 83) | 0.59 | ||
Males | 44 (69.8%) | 46 (73%) | 32 (50.8%) | 42 (66.7%) | 1.16 | 0.55 to 2.45 | 1.00 |
eGFR (mean, SD, ml/min per 1.73 m2) | 43.9 (34.1) | 48.0 (33.4) | 58.5 (31.3) | 66.4 (27.0) | <0.01 | ||
CKD 3 to 5 | 40 (63.5%) | 38 (60.3%) | 27 (42.9%) | 21 (33.3%) | 3.48 | 1.67 to 7.24 | 0.01 |
Hypertension | 49 (77.8%) | 43 (68.3%) | 35 (55.6%) | 30 (47.6%) | 3.85 | 1.78 to 8.34 | 0.01 |
Number of antihypertensives (mean, SD) | 2.2 (1.5) | 1.6 (1.3) | 0.94 (1.6) | 0.94 (1.3) | <0.01 | ||
Diabetes | 20 (31.7%) | 15 (23.8%) | 21 (33.3%) | 19 (30.2%) | 1.08 | 0.51 to 2.29 | 1.00 |
Dyslipidemia | 35/62 (56.5%) | 41/61 (67.2%) | 32/62 (51.6%) | 30/61 (49.2%) | 1.34 | 0.66 to 2.72 | 0.47 |
Smoking history | 38 (60.3%) | 35 (55.6%) | 37 (58.7%) | 41 (65.1%) | 0.82 | 0.40 to 1.68 | 0.71 |
P values, odds ratios, and 95% confidence intervals were compared between individuals in quartiles 1 and 4. CRAE, central retinal artery equivalent; eGFR, estimated GFR; CKD, chronic kidney disease.